Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−7.5 PLN
−38.43 M PLN
15.82 M PLN
3.31 M
About Captor Therapeutics SA
Sector
Industry
CEO
Michal Jerzy Walczak
Website
Headquarters
Wroclaw
Founded
2018
ISIN
PLCPTRT00014
FIGI
BBG00ZN5Z569
Captor Therapeutics SA engages in the development of protein degradation drugs for cancer and autoimmune diseases. The company was founded on November 7, 2018 and is headquartered in Wroclaw, Poland.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
ETFBS80TR
Beta ETF sWIG80TR Portfelowy Fundusz Inwestycyjny Zamkniety UnitsWeight
0.46%
Market value
182.34 K
USD
Explore more ETFs
Frequently Asked Questions
The current price of CTX is 38.8 PLN — it has decreased by −0.77% in the past 24 hours. Watch Captor Therapeutics SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GPW exchange Captor Therapeutics SA stocks are traded under the ticker CTX.
CTX stock has fallen by −5.37% compared to the previous week, the month change is a 2.92% rise, over the last year Captor Therapeutics SA has showed a −48.95% decrease.
We've gathered analysts' opinions on Captor Therapeutics SA future price: according to them, CTX price has a max estimate of 128.00 PLN and a min estimate of 128.00 PLN. Watch CTX chart and read a more detailed Captor Therapeutics SA stock forecast: see what analysts think of Captor Therapeutics SA and suggest that you do with its stocks.
CTX stock is 3.37% volatile and has beta coefficient of 0.46. Track Captor Therapeutics SA stock price on the chart and check out the list of the most volatile stocks — is Captor Therapeutics SA there?
Today Captor Therapeutics SA has the market capitalization of 216.17 M, it has decreased by −3.22% over the last week.
Yes, you can track Captor Therapeutics SA financials in yearly and quarterly reports right on TradingView.
Captor Therapeutics SA is going to release the next earnings report on Nov 20, 2025. Keep track of upcoming events with our Earnings Calendar.
CTX net income for the last quarter is −9.76 M PLN, while the quarter before that showed −10.72 M PLN of net income which accounts for 8.99% change. Track more Captor Therapeutics SA financial stats to get the full picture.
No, CTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Captor Therapeutics SA EBITDA is −44.55 M PLN, and current EBITDA margin is −250.88%. See more stats in Captor Therapeutics SA financial statements.
Like other stocks, CTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Captor Therapeutics SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Captor Therapeutics SA technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Captor Therapeutics SA stock shows the sell signal. See more of Captor Therapeutics SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.